Drug Discovery & Development

Strategies & Technologies Driving Drug Discovery to Market

Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

All Bottled Up

November 8, 2007 5:12 am | by James Netterwald, PhD, MT (ASCP), Senior Editor | Articles | Comments

Dedicated autism researchers are trying to develop animal models that allow for a better understanding of autism and may some day lead to better drugs to the disease. Rodent models of autism, while useful, have their limitations, and finding good models can be a challenge. So how does one find a good model for autism?

TOPICS:

Cholesterol-lowering Drug Linked to Sleep Disruptions

November 8, 2007 4:44 am | News | Comments

Simvastatin appears to disrupt sleep patterns of some patients.

TOPICS:

Genetic Role in Type 1 Diabetes Uncovered

November 8, 2007 4:21 am | News | Comments

Researchers identify an enzyme thought to be an important instigator of the inner-body conflict that causes Type 1 diabetes.

TOPICS:
Advertisement

Blood Pressure Drug Curbs Brain Damage

November 8, 2007 4:08 am | News | Comments

A drug used to treat high blood pressure and enlargement of the prostate may protect the brain from damage caused by post-traumatic stress disorder, Alzheimer's disease, depression and schizophrenia.

TOPICS:

Who Has the Gene?

November 7, 2007 11:36 am | by James Netterwald, PhD, MT (ASCP), Senior Editor | Articles | Comments

Phenocopy sometimes muddies up the genetic factors of disease risk, but a new way of looking at this issue soon might clean it up.

TOPICS:

Beyond Luciferase

November 7, 2007 10:35 am | by Neil Canavan, Contributing Editor | Articles | Comments

Advances in reporter gene technology aid the investigation of cellular activity. This has led to an increased number of options available to researchers.

TOPICS:

Viva in vitro

November 7, 2007 9:43 am | by The Editors of Drug Discovery & Development | Articles | Comments

Cell culture technology evolves from Ross Harrison's experiment.

TOPICS:

Much-Needed Support

November 7, 2007 9:06 am | by Primary Authors: Kelly Jenkins, Senior Principal Scientist, Pfizer Global Research and Development, La Jolla, Calif.; Gregory Samoil, Galileo Product Manager and Joel Usansky, Watson Product Manager, Thermo Fisher Scientific, Philadelphia, Pa. | Articles | Comments

LIMS may help with obstacles related to medium- and high-throughput ADME screening.

TOPICS:
Advertisement

Helping Out

November 7, 2007 8:23 am | by Nathan Collins, Executive Director, SRI International | Articles | Comments

Hiring a Contract Research Organization can expedite the drug development process.

TOPICS:

Far Eastern Dreams

November 7, 2007 7:05 am | by K. John Morrow, Jr., PhD | Articles | Comments

Asian lands experiencing up-and-downs in the biosciences continue to push forward to compete with the EU and US.

TOPICS:

Smaller Portions

November 7, 2007 6:08 am | by Gary Herman, MD, Executive Director of Experimental Medicine, Merck & Co., Inc. | Articles | Comments

Merck’s food intake model aids high-throughput screening of anti-obesity drugs.

TOPICS:

PDUFA Action Begins

November 7, 2007 4:31 am | by Ted Agres, Contributing Editor | Articles | Comments

Drug manufacturers, law-makers, and consumer groups all found much to praise in the passage of the Food and Drug Administration Amendments Act of 2007 (HR 3580), which President Bush signed into law in late September. But much will depend on how the FDA implements the roughly 200 provisions contained in the 156-page piece of legislation.

TOPICS:

Going with the Flow

November 6, 2007 11:29 am | by Mike May, Contributing Editor | Articles | Comments

With all of the cells in organisms, and cells just wandering around in the environment, scientists always seek new ways to sort them. The results unveil basic and applied value.

TOPICS:

Network Formed to Tackle Cardiac Safety Challenge

November 6, 2007 10:54 am | News | Comments

A group of companies that specialize in cardiac safety testing have joined forces to create a comprehensive and technologically advanced solution for determining how drugs affect the heart.

TOPICS:

Metastatix Granted Investigational New Drug Application for MSX-122

November 6, 2007 10:44 am | News | Comments

Metastatix announced that the US Food and Drug Administration has accepted its Investigational New Drug application for MSX-122.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading